healthcare distribution market
100 Pages | Healthcare

Global Healthcare Distribution Market Insights 2024, Analysis and Forecast to 2031, By Product Type, By End-User

  • Published Date : 2024-08-21
  • Pages : 100
  • Report Id : 40440
  • Categories : Healthcare

This report describes the global market size of Healthcare Distribution from 2019 to 2022 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2031 and its expected to grow with a CAGR of 6.7% from 2024 to 2031.

Due to the COVID-19 pandemic, the global market for Healthcare Distribution estimated at US $ 951.35 billion in the year 2023, is projected to reach a revised size of US $ 1,660.12 billion by 2031, growing at a CAGR of 6.7% during the forecast period 2024-2031.

Healthcare Distribution refers to the processes and systems involved in the delivery of medical products, pharmaceuticals, and healthcare supplies from manufacturers to end-users, including hospitals, clinics, pharmacies, and patients. It encompasses logistics, inventory management, and regulatory compliance to ensure timely and efficient access to essential healthcare products..

For geography segment, regional supply, demand, major players, price is presented from 2019 to 2031. This report cover following regions:
North America
Asia-Pacific
Europe
Middle East and Africa
South America


The key countries for each regions are also included such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report include global key players of Healthcare Distribution as well as some small players. The information for each competitor include:
Company Profile
Main Business Information
SWOT Analysis
Sales Volume, Revenue, Price and Gross Margin
Market Share

By Product Type
Pharmaceutical Distribution Services
Biopharmaceutical Distribution Service
Medical Services

In 2023, the Healthcare Distribution market is lead by the Pharmaceutical Distribution Services segment, driven by the critical need for efficient delivery of medications and adherence to stringent regulatory standards.
Biopharmaceutical Distribution Services follows closely, supported by the increasing demand for complex and temperature-sensitive biologics and advanced therapies.
While Medical Services caters to niche needs, including the distribution of specialized medical supplies and equipment essential for various healthcare procedures and patient care.

By End-User
Retail Pharmacies
Hospital Pharmacies
Other


In 2023, the Healthcare Distribution market is predominantly driven by Retail Pharmacies, which lead the market due to their extensive network and high demand for over-the-counter and prescription medications.
Hospital Pharmacies follow closely, driven by their essential role in providing medications and medical supplies directly within healthcare facilities and supporting inpatient care.
The other segments include niche segments such as long-term care facilities, specialty clinics, and home healthcare providers, addressing specific distribution needs for various healthcare settings.


Company-
McKesson Corporation
Cardinal Health
Morris and Dickson Company
Smith Drug Company
Owens and Minor Inc
Patterson Companies
PHOENIX Pharmahandel SE
Shanghai Pharmaceutical Group
Medline Industries
CuraScript SD


Please ask for sample pages for full companies list

Base Year: 2023
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2031

Any special requirements about this report, please let us know and we can provide custom report.


TABLE OF CONTENTS

Market Taxonomy
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis and Recommendations
1.3. Analysis and Recommendations
2. Market Introduction
2.1. Market Definition
3. Market Background
3.1. Parent/Associated Market Overview
3.1.1.Healthcare Distribution Outlook
3.1.2.Healthcare Distribution Overview
3.2. Macro-Economic Overview
3.2.1. GDP Growth
3.2.2. Retail Industry Growth
3.3. Pricing Analysis
3.4. Challenges related to adoption of Healthcare Distribution
3.5. Regulations of Healthcare Distribution
3.6. Forecast Factors: Relevance and Impact
3.7. Market Dynamics
3.7.1. Drivers
3.7.2. Restraints
3.7.3. Opportunity
3.7.4. Trends
3.7.5. SWOT Analysis
4. Market Forecast
4.1. Market Value Projections
4.2. Market Size Projections
4.3. Y-o-Y Projections
4.4. Absolute Opportunity Analysis
5. Global Healthcare Distribution Market Value Chain Analysis
5.1.Healthcare Distribution Value Chain
5.1.1. List of Raw Material Suppliers
5.1.2. List of Healthcare Distribution Manufacturer
5.1.3. List of Segment
6. Global Healthcare Distribution Market Analysis By Product Type
6.1. Introduction
6.1.1. Market Value Share Analysis By Product Type
6.1.2. Y-o-Y Growth Analysis By Product Type
6.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Product Type
6.3. Market Attractiveness Analysis Product Type
7. Global Healthcare Distribution Analysis By End-User
7.1. Introduction
7.1.1. Market Value Share Analysis By End-User
7.1.2. Y-o-Y Growth Analysis By End-User
7.2. Historical Market Size (USD Mn) Analysis 2018-2022 By End-User
7.3. Market Attractiveness Analysis By End-User
8. Market Structure Analysis
8.1. Market Analysis by Tier of Companies
8.1.1. By Large, Medium, and Small
8.2. Market Concentration
8.2.1. By Top 5 and by Top 10
8.3. Type ion Capacity Share Analysis
8.3.1. By Large, Medium, and Small
8.3.2. By Top 5 and Top 10
8.4. Product Type Roadmap
9. Competition Analysis
9.1. Competition Dashboard
9.2. Company Profiles (15 Companies)
9.2.1.McKesson Corporation
9.2.1.1. Overview
9.2.1.2. Type Portfolio
9.2.1.3. Financial Overview
9.2.2. Cardinal Health
9.2.2.1. Overview
9.2.2.2. Type Portfolio
9.2.2.3. Financial Overview
9.2.3. Morris and Dickson Company
9.2.3.1. Overview
9.2.3.2. Type Portfolio
9.2.3.3. Financial Overview
9.2.4. Smith Drug Company
9.2.4.1. Overview
9.2.4.2. Type Portfolio
9.2.4.3. Financial Overview
9.2.5. Owens and Minor Inc
9.2.5.1. Overview
9.2.5.2. Type Portfolio
9.2.5.3. Financial Overview
9.2.6. Patterson Companies
9.2.6.1. Overview
9.2.6.2. Type Portfolio
9.2.6.3. Financial Overview
9.2.7. PHOENIX Pharmahandel SE
9.2.7.1. Overview
9.2.7.2. Type Portfolio
9.2.7.3. Financial Overview
9.2.8. Shanghai Pharmaceutical Group
9.2.8.1. Overview
9.2.8.2. Type Portfolio
9.2.8.3. Financial Overview
9.2.9. Medline Industries
9.2.9.1. Overview
9.2.9.2. Type Portfolio
9.2.9.3. Financial Overview
9.2.10. CuraScript SD
9.2.10.1. Overview
9.2.10.2. Type Portfolio
9.2.10.3. Financial Overview
9.2.11. COMPANY11
9.2.11.1. Overview
9.2.11.2. Type Portfolio
9.2.11.3. Financial Overview
9.2.12. COMPANY12
9.2.12.1. Overview
9.2.12.2. Type Portfolio
9.2.12.3. Financial Overview
9.2.13. COMPANY13
9.2.13.1. Overview
9.2.13.2. Type Portfolio
9.2.13.3. Financial Overview
9.2.14. COMPANY14
9.2.14.1. Overview
9.2.14.2. Type Portfolio
9.2.14.3. Financial Overview
9.2.15. COMPANY15
9.2.15.1. Overview
9.2.15.2. Type Portfolio
9.2.15.3. Financial Overview
10. Global Healthcare Distribution Market Analysis By Region
10.1. Introduction
10.1.1. Market Value Share Analysis By Region
10.1.2. Y-o-Y Growth Analysis By Region
10.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Region
10.2.1. North America
10.2.2. Middle East and Africa
10.2.3. South America
10.2.4. Asia-Pacific
10.2.5. Others
10.3. Current Market Size (USD Mn) Forecast 2023-2030 By Region
10.3.1. North America
10.3.2. Middle East and Africa
10.3.3. South America
10.3.4. Asia-Pacific
10.3.5. Others
10.4. Market Attractiveness Analysis By Region
11. North America Healthcare Distribution Analysis
11.1. Introduction
11.2. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
11.2.1. U.S.
11.2.2. Canada
11.2.3. Mexico
11.2.4. Rest of North America
11.3. Current Market Size (USD Mn) Forecast 2023-2030 By Country
11.3.1. U.S.
11.3.2. Canada
11.3.3. Mexico
11.3.4. Rest of North America
11.4. Historical Market Size (USD Mn) Analysis 2018-2022 By Product Type
11.5. Current Market Size (USD Mn) Forecast 2023-2030 By Product Type
11.6. Historical Market Size (USD Mn) Analysis 2018-2022 By End-User
11.7. Current Market Size (USD Mn) Forecast 2023-2030 By End-User
12. South America Healthcare Distribution Analysis
12.1. Introduction
12.2. Regional Pricing Analysis
12.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
12.3.1. Brazil
12.3.2. Argentina
12.3.3. Rest of South America
12.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
12.4.1. Brazil
12.4.2. Argentina
12.4.3. Rest of South America
12.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Product Type
12.6. Current Market Size (USD Mn) Forecast 2023-2030 By Product Type
12.7. Historical Market Size (USD Mn) Analysis 2018-2022 By End-User
12.8. Current Market Size (USD Mn) Forecast 2023-2030 By End-User
13. Europe Healthcare Distribution Analysis
13.1. Introduction
13.2. Regional Pricing Analysis
13.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
13.3.1. Germany
13.3.2. Italy
13.3.3. France
13.3.4. Spain
13.3.5. U.K.
13.3.6. Rest of Europe
13.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
13.4.1. Germany
13.4.2. Italy
13.4.3. France
13.4.4. Spain
13.4.5. U.K.
13.4.6. Rest of Europe
13.5. Historical Market Size (USD Mn) Analysis 2018-2022 By Product Type
13.6. Current Market Size (USD Mn) Forecast 2023-2030 By Product Type
13.7. Historical Market Size (USD Mn) Analysis 2018-2022 By End-User
13.8. Current Market Size (USD Mn) Forecast 2023-2030 By End-User
14. Middle East and Africa Healthcare Distribution Analysis
14.1. Introduction
14.2. Regional Pricing Analysis
14.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
14.3.1. Saudi Arabia
14.3.2. U.A.E.
14.3.3. South Africa
14.3.4. Turkey
14.3.5. Rest of Middle East and Africa
14.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
14.4.1. Saudi Arabia
14.4.2. U.A.E.
14.4.3. South Africa
14.4.4. Turkey
14.4.5. Rest of Middle East and Africa
15. Asia-Pacific Healthcare Distribution Analysis
15.1. Introduction
15.2. Regional Pricing Analysis
15.3. Historical Market Size (USD Mn) Analysis 2018-2022 By Country
15.3.1. China
15.3.2. India
15.3.3. Japan
15.3.4. South Korea
15.3.5. Singapore
15.3.6. Australia and New Zealand
15.3.7. Rest of Asia-Pacific
15.4. Current Market Size (USD Mn) Forecast 2023-2030 By Country
15.4.1. China
15.4.2. India
15.4.3. Japan
15.4.4. South Korea
15.4.5. Singapore
15.4.6. Australia and New Zealand
15.4.7. Rest of Asia-Pacific
i. Research Methodology
ii. Assumptions & Acronyms


LIST OF FIGURES

Figure 01: Global Healthcare Distribution Market, BPS Analysis, By Product Type , 2018(H), 2023(E) & 2030(F)
Figure 02: Global Healthcare Distribution Market, Y-O-Y Growth, By Product Type , 2020(A) - 2030(F)
Figure 03: Global Healthcare Distribution Market Attractiveness Analysis, By Product Type (2020)
Figure 04: Global Healthcare Distribution Market, BPS Analysis, By End-User, 2018(H), 2023(E) & 2030(F)
Figure 05: Global Healthcare Distribution Market, Y-O-Y Growth, By End-User, 2018(H) - 2030(F)
Figure 06: Global Healthcare Distribution Market Attractiveness Analysis, By End-User
Figure 07: Global Healthcare Distribution Market, Value Analysis, By Product Type , 2018(H)-2030(F)
Figure 08: Global Healthcare Distribution Market, Value Analysis, by Material , 2018(H)-2030(F)
Figure 09: Global Healthcare Distribution Market, BPS Analysis, by Region, 2018(H), 2023(E) & 2030(F)
Figure 10: Global Healthcare Distribution Market, Y-O-Y Growth, by Region, 2018(H) - 2030(F)
Figure 11: Global Healthcare Distribution Market Attractiveness Analysis, by Region
Figure 12: North America Healthcare Distribution Value (USD Mn Forecast, 2018 – 2022
Figure 13: North America Healthcare Distribution Value (USD Mn Forecast, 2023 – 2030
Figure 14: South America Healthcare Distribution Value (USD Mn) Forecast, 2018 – 2022
Figure 15: South America Healthcare Distribution Value (USD Mn) Forecast, 2023 – 2030
Figure 16: Europe Healthcare Distribution Value (USD Mn) Forecast, 2018 – 2022
Figure 17: Europe Healthcare Distribution Value (USD Mn) Forecast, 2023 – 2030
Figure 18: Middle East and Africa Healthcare Distribution Value (USD Mn) Forecast, 2018 – 2022

LIST OF TABLES

Table 01: Global Healthcare Distribution Market Value (USD Mn) Forecast, By Product Type , 2018(H) – 2030(F)
Table 02: Global Healthcare Distribution Market Value (USD Mn) Forecast, By End-User, 2018(H) – 2030(F)
Table 03: Global Healthcare Distribution Market Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 04: North America Healthcare Distribution Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 05: North America Healthcare Distribution Value (USD Mn) Forecast, By Product Type , 2018(H) – 2030(F)
Table 06: North America Healthcare Distribution Value (USD Mn) Forecast, By End-User, 2018(H) – 2030(F)
Table 07: South America Healthcare Distribution Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 08: South America Healthcare Distribution Value (USD Mn) Forecast, By Product Type , 2018(H) – 2030(F)
Table 09: South America Healthcare Distribution Value (USD Mn) Forecast, By End-User, 2018(H) – 2030(F)
Table 10: Europe Healthcare Distribution Value (USD Mn) and Forecast, By Country, 2018(H) – 2030(F)
Table 11: Europe Healthcare Distribution Value (USD Mn) Forecast, By Product Type , 2018(H) – 2030(F)
Table 12: Europe Healthcare Distribution Value (USD Mn) Forecast, By End-User End User, 2018(H) – 2030(F)
Table 13: Middle East and Africa Healthcare Distribution Value (USD Mn) Forecast, By Country, 2018(H) – 2030(F)
Table 14: Middle East and Africa Healthcare Distribution Value (USD Mn) Forecast, By Product Type , 2018(H) – 2030(F)
Table 15: Middle East and Africa Healthcare Distribution Value (USD Mn) Forecast, By End-User, 2018(H) – 2030(F)
Table 16: Asia-Pacific Healthcare Distribution Value (USD Mn) Forecast, by Country, 2018(H) – 2030(F)
Table 17: Asia-Pacific Healthcare Distribution Value (USD Mn) Forecast, By Product Type , 2018(H) – 2030(F)
Table 18: Asia-Pacific Healthcare Distribution Value (USD Mn) Forecast, By End-User, 2018(H) – 2030(F)

Direct Purchase
Your perfect start with Stats And Research


Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.
RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo RA client logo
×

Avail PDF Sample Reports

You may also be lnterested in..

Stats And Research Copyright © 2024 .